Most of the successful anti-nematode drugs currently available affect the nematode locomotory system. Their success is due to their interactions with molecules associated with the main neuro-transmitters of the motor nervous system, acetylcholine and GABA. These drugs tend to have a relatively broad spectrum of action, affecting a wide variety of nematodes, presumably because nematode motor nervous systems are conservative in their use of these transmitters.